The neutrophil-lymphocyte ratio is associated with postoperative mortality of cardiac surgery

Background The neutrophil-lymphocyte ratio (NLR) has been recognized as a useful marker of poor prognosis in non-cardiac surgery patients. But, the prognostic function of NLR in cardiovascular surgery patients still largely unknown. The aim of this study was to explore the relationship between postoperative NLR and mortality in cardiac surgery patients. Methods Clinical data were extracted from the Medical Information Mart for Intensive Care III (MIMIC-III) database. Postoperative day 1 (POD-1) NLR of the patients was calculated. All patients were divided into two groups according to the cut-off value of NLR, which was determined using the receiver operating characteristic (ROC) curve and Youden Index. The primary death outcomes were 30-day, 90-day and 1-year mortality. Cox proportional hazard analysis was performed to assess the associations between NLR and 1-year mortality. Logistic analysis was performed to assess the associations between NLR and other outcomes. Multivariate analyses were used to control for confounders. Results A total of 2,707 cardiac surgery patients were included in this study. The cut-off value of postoperative NLR was 7.28. Elevated postoperative NLR was associated with increased death outcomes including 30-day mortality [adjusted odds ratio (OR) 2.25, P=0.019], 90-day mortality (adjusted OR 2.49, P=0.001) and 1-year mortality [adjusted hazard ratio (HR) 1.58, P=0.03] of cardiac surgery in cox proportional hazard model. Elevated NLR was also associated with increased risk of continuous renal replacement therapy (CRRT) rate (adjusted OR 3.01, P=0.004), prolonged ICU stays (adjusted OR 2.55, P<0.001), prolonged hospital stays (adjusted OR 3.32, P<0.001) and duration of ventilatory support (adjusted OR 4.16, P<0.001) after adjusting confounders. Conclusions Elevated postoperative NLR was significantly associated with increased short-term and long-term mortality, CRRT rate, longer ICU and hospital stay, prolonged ventilation in patients undergoing cardiac surgery. NLR is promising to be a readily available and independent prognostic biomarker for patients with cardiac surgery.

[1]  Elshaimaa Seaoud,et al.  The Role of the Platelet/Lymphocyte Ratio and Neutrophil/Lymphocyte Ratio in Predicting High-Risk Heart Score in Patients Admitted with Non-ST Elevation Acute Coronary Syndrome , 2020, Pulse.

[2]  A. Yüksel,et al.  Predictive Value of Neutrophil-Lymphocyte Ratio for Long-Term Cardiovascular Event Following Coronary Artery Bypass Grafting , 2020, Brazilian journal of cardiovascular surgery.

[3]  Huarui Bao,et al.  Diagnostic Value of Neutrophil-Lymphocyte Ratio for Predicting the Severity of Acute Pancreatitis: A Meta-Analysis , 2020, Disease markers.

[4]  P. Steele,et al.  Pre-operative neutrophil–lymphocyte ratio predicts low cardiac output in children after cardiac surgery , 2020, Cardiology in the Young.

[5]  L. Perry,et al.  The Prognostic Value of Elevated Perioperative Neutrophil-Lymphocyte Ratio in Predicting Postoperative Atrial Fibrillation After Cardiac Surgery: A Systematic Review and Meta-Analysis. , 2019, Heart, lung & circulation.

[6]  C. Krawczeski Cardiopulmonary Bypass and AKI: AKI Is Bad, So Let's Get Beyond the Diagnosis , 2019, Front. Pediatr..

[7]  Hao Xu,et al.  The Relationship Between Neutrophil to Lymphocyte Ratio and Clinical Outcome in Pediatric Patients After Cardiopulmonary Bypass Surgery: A Retrospective Study , 2019, Frontiers in Pediatrics.

[8]  P. Guida,et al.  Prevalence and Clinical Impact of Systemic Inflammatory Reaction After Cardiac Surgery. , 2019, Journal of cardiothoracic and vascular anesthesia.

[9]  M. Da Costa,et al.  The use of neutrophil lymphocyte ratio to predict complications post cardiac surgery. , 2019, Annals of translational medicine.

[10]  M. Ranucci,et al.  Inflammation and coagulation following minimally invasive extracorporeal circulation technologies. , 2019, Journal of thoracic disease.

[11]  T. Hilbert,et al.  Cerebral Function and Perfusion during Cardiopulmonary Bypass: A Plea for a Multimodal Monitoring Approach. , 2018, The heart surgery forum.

[12]  J. Emond,et al.  Pretreatment neutrophil–lymphocyte ratio: useful prognostic biomarker in hepatocellular carcinoma , 2018, Journal of hepatocellular carcinoma.

[13]  O. Merin,et al.  Neutrophil-Lymphocyte Ratio: Prognostic Impact in Heart Surgery. Early Outcomes and Late Survival. , 2017, The Annals of thoracic surgery.

[14]  F. Quereshy,et al.  Postoperative day one neutrophil-to-lymphocyte ratio as a predictor of 30-day outcomes in bariatric surgery patients , 2017, Surgical Endoscopy.

[15]  M. Gaudino,et al.  Acute respiratory distress syndrome after cardiac surgery. , 2016, Journal of thoracic disease.

[16]  D. Mikhailidis,et al.  The Relation Between Atherosclerosis and the Neutrophil–Lymphocyte Ratio , 2016, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[17]  J. Lopez-Delgado,et al.  The inflammatory response in cardiac surgery: an overview of the pathophysiology and clinical implications. , 2014, Inflammation & allergy drug targets.

[18]  H. Nathoe,et al.  White blood cell count and new-onset atrial fibrillation after cardiac surgery , 2014, Critical Care.

[19]  G. Hillis,et al.  Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. , 2010, The American journal of cardiology.

[20]  J. Schold,et al.  Acute Kidney Injury Is Associated With Increased Long-Term Mortality After Cardiothoracic Surgery , 2009, Circulation.

[21]  J. Bonventre,et al.  Ischemic acute renal failure: an inflammatory disease? , 2004, Kidney international.

[22]  John G. Laffey,et al.  The Systemic Inflammatory Response to Cardiac Surgery: Implications for the Anesthesiologist , 2002, Anesthesiology.

[23]  M. Kollef,et al.  Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. , 1995, Chest.

[24]  S. Khuri,et al.  Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. , 1992, The Journal of thoracic and cardiovascular surgery.

[25]  J HOUEL,et al.  [Cardiac surgery]. , 1954, Afrique francaise chirurgicale.